Research Report: HIMS

Analysis Date: 2025-12-09T20:06:30.214307 Trading Period: 2025-12-08 to 2025-12-19

Company Overview

Company: Hims & Hers Health, Inc. Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic Current Price: $39.21 Market Cap: $8,926,098,432 Beta: 2.41 Avg Volume: 27,103,688 P/E Ratio: 73.98 Website: https://www.hims.com

Description: Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over...

Trading Recommendation

Action: STRONG AVOID Confidence: 20.0/100 Position Size: 0.0% of portfolio

Rationale: Unfavorable conditions (composite: 34.2/100, risk: EXTREME, red flags: 2).

Key Risks:

Screening Status

Passed Filters: ✓ Yes Notes: Passed all screening filters

Quantitative Analysis

Composite Score: 3.20/5.0 Percentile Rank: 100%

Factor Scores:

Technical Analysis

Setup Score: 2/8 Setup Notes: In uptrend; Strong weekly momentum

Price Levels:

Momentum & Volume:

Risk Assessment

Risk Level: EXTREME Confidence: 10.0/100 Total Red Flags: 2 Earnings Risk: No

Critical Issues:

Stock-Specific Red Flags:


This report is generated by PM automated research system. Always perform your own due diligence before trading.